LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Ebrahim, Neven A.; Leach, Lopa (2015)
Publisher: Mary Ann Liebert
Languages: English
Types: Article
Subjects: Original Research Reports
Mesenchymal stem cells from Wharton's jelly of human umbilical cords (WJ-MSC) are a valuable alternate source of stem cells. Their role in situ and whether they can interact and cross intact endothelial monolayers requires elucidation. The aim of this study was to investigate the dynamic interactions between WJ-MSC and human umbilical vein endothelial cells (HUVEC), including attachment, transit times, extravasation pathway, and the effects of WJ-MSC on junctional vascular endothelial (VE)-cadherin. HUVEC were grown to near confluence in endothelial media and to full confluence in mixed media before the addition of PKH26-labelled WJ-MSC. Time lapse fluorescence microscopy showed stem cells undergoing membrane blebbing followed by amoeboid movement on HUVEC monolayers before rounding up and changing shape toward the spindle-shaped morphology during/after transmigration to subendothelial positions. Cells demonstrated a time lag of 60 min before paracellular extravasation, confirmed by confocal microscopy. Forty-six percent of attached cells crossed in the first 2 h. By 16 h, a majority of cells had transmigrated with >96% of cells crossing by 22 h. There were concomitant changes in endothelial junctional VE-cadherin with statistically significant increases in discontinuous staining at 2 h, return to control values at 16 h, even as from 22 h onward HUVEC displayed increased percentage of junctions with continuous staining and upregulation of protein. Our data suggests that WJ-MSC crosses the endothelial barrier through the paracellular pathway and can influence junctional organization of HUVEC with discreet perturbation of VE-cadherin preceding transmigration followed by upregulation once the adluminal side is reached. The latter may reflect a perivascular support function of WJ-MSC in the umbilical cord.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. Kobayashi K, T Kubota and T Aso. (1998). Study on myofibroblast differentiation in the stromal cells of Wharton's jelly: expression and localization of alpha-smooth muscle actin. Early Hum Dev 51:223-233.
    • 2. Fan CG, QJ Zhang and JR Zhou. (2011). Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord. Stem Cell Rev 7:195-207.
    • 3. Sokolova IB, NN Zin'kova, EV Shvedova, PV Kruglyakov and DG Polyntsev. (2007). Distribution of mesenchymal stem cells in the area of tissue inflammation after transplantation of the cell material via different routes. Bull Exp Biol Med 143:143-146.
    • 4. Teo GS, JA Ankrum, R Martinelli, SE Boetto, K Simms, TE Sciuto, AM Dvorak, JM Karp and CV Carman. (2012). Mesenchymal stem cells transmigrate between and directly through tumor necrosis factor-alpha-activated endothelial cells via both leukocyte-like and novel mechanisms. Stem Cells 30:2472-2486.
    • 5. Schmidt A, D Ladage, C Steingen, K Brixius, T Schinkothe, FJ Klinz, RH Schwinger, U Mehlhorn and W Bloch. (2006). Mesenchymal stem cells transmigrate over the endothelial barrier. Eur J Cell Biol 85:1179-1188.
    • 6. Dejana E, F Orsenigo and MG Lampugnani. (2008). The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci 121:2115-2122.
    • 7. De Bruyn C, M Najar, G Raicevic, N Meuleman, K Pieters, B Stamatopoulos, A Delforge, D Bron and L Lagneaux. (2011). A rapid, simple, and reproducible method for the isolation of mesenchymal stromal cells from Wharton's jelly without enzymatic treatment. Stem Cells Dev 20:547- 557.
    • 8. Dominici M, K Le Blanc, I Mueller, I Slaper-Cortenbach, F Marini, D Krause, R Deans, A Keating, Dj Prockop and E Horwitz. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315- 317.
    • 9. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
    • 10. Santos JM, RN Barcia, SI Simoes, MM Gaspar, S Calado, A Agua-Doce, SC Almeida, J Almeida, M Filipe, et al. (2013). The role of human umbilical cord tissue-derived mesenchymal stromal cells (UCX(R)) in the treatment of inflammatory arthritis. J Transl Med 11:18.
    • 11. Hamilton RD and L Leach. (2011). Isolation and properties of an in vitro human outer blood-retinal barrier model. Methods Mol Biol 686:401-416.
    • 12. Pati S, AY Khakoo, J Zhao, F Jimenez, MH Gerber, M Harting, JB Redell, R Grill, Y Matsuo, et al. (2011). Human mesenchymal stem cells inhibit vascular permeability by modulating vascular endothelial cadherin/beta-catenin signaling. Stem Cells Dev 20:89-101.
    • 13. Esser S, MG Lampugnani, M Corada, E Dejana and W Risau. (1998). Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. J Cell Sci 111:1853-1865.
    • 14. Leach L, BM Eaton, ED Westcott and JA Firth. (1995). Effect of histamine on endothelial permeability and structure and adhesion molecules of the paracellular junctions of perfused human placental microvessels. Microvasc Res 50:323-337.
    • 15. Absi M, JI Bruce and DT Ward. (2014). The inhibitory effect of simvastatin and aspirin on histamine responsiveness in human vascular endothelial cells. Am J Physiol Cell Physiol 306:C679-C686.
    • 16. Bates DO. (2010). Vascular endothelial growth factors and vascular permeability. Cardiovasc Res 87:262-271.
    • 17. Wegener J and J Seebach. (2014). Experimental tools to monitor the dynamics of endothelial barrier function: a survey of in vitro approaches. Cell Tissue Res 355:485- 514.
    • 18. Lin MN, DS Shang, W Sun, B Li, X Xu, WG Fang, WD Zhao, L Cao and YH Chen. (2013). Involvement of PI3K and ROCK signaling pathways in migration of bone marrow-derived mesenchymal stem cells through human brain microvascular endothelial cell monolayers. Brain Res 1513:1-8.
    • 19. Menge T, M Gerber, K Wataha, W Reid, S Guha, CS Cox, Jr., P Dash, MS Reitz, Jr., AY Khakoo and S Pati. (2013). Human mesenchymal stem cells inhibit endothelial proliferation and angiogenesis via cell-cell contact through modulation of the VE-Cadherin/beta-catenin signaling pathway. Stem Cells Dev 22:148-157.
    • 20. Choi M, HS Lee, P Naidansaren, HK Kim, E O, JH Cha, HY Ahn, PI Yang, JC Shin and YA Joe. (2013). Proangiogenic features of Wharton's jelly-derived mesenchymal stromal/stem cells and their ability to form functional vessels. Int J Biochem Cell Biol 45:560- 570.
    • 21. Salomon C, J Ryan, L Sobrevia, M Kobayashi, K Ashman, M Mitchell and GE Rice. (2013). Exosomal signaling during hypoxia mediates microvascular endothelial cell migration and vasculogenesis. PLoS One 8:e68451.
    • 22. Lv FJ, RS Tuan, KM Cheung and VY Leung. (2014). The surface markers and identity of human mesenchymal stem cells. Stem Cells 32:1408-1419.
    • 23. Norman LL, J Brugues, K Sengupta, P Sens and H ArandaEspinoza. (2010). Cell blebbing and membrane area homeostasis in spreading and retracting cells. Biophys J 99:1726-1733.
    • 24. Stock C and C Riethmuller. (2011). Endothelial activation drives lateral migration and diapedesis of leukocytes. Cell Immunol 271:180-183.
  • No related research data.
  • No similar publications.

Share - Bookmark

Funded by projects

Cite this article